ITGR Integer Holdings Corporation

GMED vs. ITGR: Which Stock Is the Better Value Option?

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

ITGR's $127-a-share KKR deal offers defined cash value, while core franchises face slow new-product adoption.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including Integer Holdings (NYSE:ITGR) and its peers.

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

KKR has fallen sharply this year, even after a strong multi year run. This puts fresh focus on whether the current US$100 share price still lines up with what its earnings can support. With the stock moving and the deal pipeline active, investors are asking how much of KKR's profit engine is already reflected in today's valuation. Over the past 5 years the share price has gained 64.1%. As a result, a lot of long term value creation is already being tested against the strength and resilience...

GMED vs. ITGR: Which Stock Is the Better Value Option?

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.

Integer's $5.7 billion KKR buyout offers shareholders $127 per share in cash, but closing still hinges on stockholder and regulatory approvals.

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.

GMED vs. ITGR: Which Stock Is the Better Value Option?

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 26.1% over the past six months, topping the S&P 500 by 13.1 percentage points.

GMED vs. ITGR: Which Stock Is the Better Value Option?

ITGR beats Q2 earnings and revenue estimates, but sales and margins decrease as product headwinds persist ahead of its $5.7B KKR deal.

KKR (KKR) is in focus after reports that it is nearing a takeover of medical device outsourcer Integer Holdings for about $4.3 billion, with an indicated offer of $127 per share. See our latest analysis for KKR. At a share price of US$105.65, KKR has recently shown firm short term momentum with a 7 day share price return of 6.42% and 30 day return of 10.09%. However, the year to date share price return is down 18.04% and the 1 year total shareholder return is down 26.43%. This is set against...

The updated analyst model for Integer Holdings now points to a fair value of US$112.14, up from US$97.56, which reflects a roughly 15% uplift in the price target. Much of this shift ties back to fresh Street commentary following KKR’s agreed all cash offer of US$127 per share, with analysts reframing views around the stock through the lens of deal terms and closing risk. As you read on, you will see how this new price target fits into the evolving narrative around Integer Holdings and what it...

Shares of medical technology company Integer Holdings (NYSE:ITGR) jumped 2.7% in the afternoon session after the company agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion, while also reporting second-quarter results that topped Wall Street expectations.

Integer Holdings (ITGR) has moved into the spotlight after reporting second quarter 2026 earnings alongside a pending all cash acquisition by KKR. Both updates give you fresh information to assess the stock. See our latest analysis for Integer Holdings. Integer Holdings shares have reacted sharply to the proposed US$127 per share cash offer, with a 7 day share price return of 23.98% and a 90 day share price return of 44.22%, while the 5 year total shareholder return of 38.00% highlights a...

Completion of the deal is subject to shareholder and regulatory approvals and is anticipated by the end of the year.

(Updates with latest market prices and developments.) US stocks climbed intraday as oil prices fe

Investment firm KKR has struck a deal to acquire medical-device outsourcing company Integer Holdings for $127 a share.

The headline numbers for Integer (ITGR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Integer (ITGR) has agreed to be acquired and taken private by investment firm KKR (KKR) in an all-ca

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.5%, and the actively tra

Integer Holdings Corporation (NYSE:ITGR) reported second-quarter 2026 results on Monday that came in ahead of analyst expectations, while also announcing a definitive agreement to be acquired by KKR in an all-cash transaction. The medical device outsourcing specialist saw its shares rise 2.

Integer expects to gain flexibility and capital to invest in its contract development and manufacturing business under KKR.

Integer (ITGR) delivered earnings and revenue surprises of +15.94% and +2.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Medical technology company Integer Holdings (NYSE:ITGR) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 2.6% year on year to $464.1 million. Its non-GAAP profit of $1.60 per share was 15.8% above analysts’ consensus estimates.

(Bloomberg) -- KKR has agreed to buy US medical device company Integer Holdings Corp. in an all-cash deal valued at about $5.7 billion.Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosTrump Says Iran Talks to Begin Monday After Scrapping AttackSingapore's Gated Island for the Rich Is Marred by Decayed HomesAlibaba Adds to China AI Breakthroughs With New Qwen Model Integer stockholders will receive $127 per shar

Investing.com -- Integer Holdings (NYSE:ITGR) shares surged 21% Friday afternoon following a Wall Street Journal report that private-equity firm KKR is near a deal to take the medical-device outsourcing company private.

Private-equity firm KKR is near a deal to take medical-device outsourcing company Integer Holdings private, according to people familiar with the matter. The deal, which could come as soon as next week, would value the Plano, Texas-based company at roughly $127 a share, the people said. There are no guarantees a deal will come together.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

A number of stocks fell in the afternoon session after a key industry player warned that changes to some insurance plans could slow U.S. procedure growth, sparking fears of a sector-wide slowdown. The concern was raised by Intuitive Surgical, which noted that shifting insurance coverage could dampen the number of medical procedures performed in the United States. This news has investors worried about near-term demand, not just for one company, but for the entire industry reliant on a steady volu

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including Integer Holdings (NYSE:ITGR) and its peers.

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.